Business, energy, technology, markets and global industry news from Business News Today

Zyprexa Relprevv

PharmaDeviceNews Zyprexa Relprevv
Editorial infographic highlighting Medincell’s second FDA-approved drug, Weltruza, featuring an injectable medicine, FDA approval symbol, U.S. launch map and graphics illustrating clinical evidence, royalty potential and commercial outlook.
Pharma & Biotech

Can Weltruza become Medincell’s next growth driver after Uzedy commercial success?

Medincell gains a second FDA-approved drug as Teva prepares Weltruza's U.S. launch. See the clinical evidence, royalties and commercial outlook.

Read More
Infographic showing FDA approval of Teva’s Weltruza, a monthly subcutaneous olanzapine that requires no loading doses, oral supplementation or post-injection monitoring.
Pharma & Biotech

Teva wins FDA approval for Weltruza as monthly olanzapine changes schizophrenia LAI equation

Teva’s Weltruza wins FDA approval as a monthly subcutaneous olanzapine without loading doses, oral supplementation or post-injection monitoring.

Read More